Table 3.
Resting anaesthetised haemodynamic parameters obtained before the administration of vasoactive substances
| Group |
SBP |
DBP |
MAP |
PP |
HR |
Peak dP/dt |
PWV |
|---|---|---|---|---|---|---|---|
| (mmHg) | (mmHg) | (mmHg) | (mmHg) | (beats/min) | (mmHg/s) | (m/s) | |
| Control |
155 ± 15# |
113 ± 15# |
130 ± 28# |
41 ± 3 |
462 ± 46 |
4024 ± 617 |
4.5 ± 0.5# |
| Diabetes |
142 ± 13# |
105 ± 13# |
124 ± 14# |
38 ± 9 |
386 ± 48*# |
2186 ± 198*# |
4.6 ± 0.9# |
| Diabetes + telmisartan | 110 ± 14 | 75 ± 14 | 92 ± 12 | 35 ± 5 | 321 ± 26* | 3294 ± 183* | 3.6 ± 0.3 |
SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; HR, heart rate; dP/dt, maximal change in pressure over time; PWV, pulse wave velocity.
* P <0.01 vs Control; #P <0.01 vs Diabetes + telmisartan.